Evaluation of Eflornithine on Facial and Forearm Skin

Study Identifier
SPD488-401
CT.gov Identifier
NCT00152048
EudraCT Identifier
2004-000726-78
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Other
    • Study Drug
  • Eflornithine hydrochloride
    • Phase
    Phase 4
    Sex
    Female
    Age
    18 - 85 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Female subjects with clinical diagnosis of facial hirsutism/excessive facial hair * Women of childbearing potential must agree to use an effective form of birth control for the duration of the study * Skin type I-IV * Customary frequency of removal of facial hair two or more times per week
    Exclusion Criteria:
    * Pregnant or lactating women * Severe inflammatory acne or presence of significant scarring on the face * History of skin malignancy * Connective tissue disorders

    Protocol Summary

    The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms

    Study Locations

    No locations found.